QIAGEN Lower Ahead of Earnings

Published on Monday, 30 January 2012 13:52 Written by Danny Miller

New York, January 30th (TradersHuddle.com) - Shares of QIAGEN N.V. (NASDAQ:QGEN) are trading lower by -1.07% ahead of its quarterly earnings release. QIAGEN, the sample and assay technologies provider is expected to release its quarterly results on January 31^st.

Wall Street Analysts consensus calls for a profit of $0.27 a share on $322.76 million revenue.

QIAGEN estimates have a range of $0.04 a share. The high estimate calls for profit of $0.29 a share and the low estimate is calling for a profit of $0.25 a share, a year ago for the quarter the company reported $0.24 a share.

QIAGEN N.V. (NASDAQ:QGEN) provides sample and assay technologies. Its technologies are used to process biological samples and to analyze DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.

Other companies on the watch on this earnings event are Sigma-Aldrich Corporation NASDAQ:SIAL and Life Technologies Corporation NASDAQ:LIFE.